Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nuveen Taxable Municipal Fund | NBB | Jan 31, 2025 | 15.89 | +0.76 |
Nuveen Variable Rate Pref Fund | NPFD | Jan 31, 2025 | 19.17 | +0.63 |
Nuveen Virginia Quality Municipal Income Fund | NPV | Jan 31, 2025 | 12.60 | +0.16 |
Nuvve | NVVE | Jan 31, 2025 | 2.43 | -10.00 |
Nuwellis | NUWE | Jan 31, 2025 | 1.23 | -1.60 |
NV5 Global | NVEE | Jan 31, 2025 | 18.84 | +3.40 |
NVE | NVEC | Jan 31, 2025 | 71.66 | -0.06 |
nVent Electric | NVT | Jan 31, 2025 | 65.09 | -1.47 |
NVIDIA | NVDA | Jan 31, 2025 | 120.07 | -3.67 |
Nvni Group | NVNI | Jan 31, 2025 | 5.66 | +0.53 |
NVR | NVR | Jan 31, 2025 | 8 016.18 | -1.53 |
NWTN B | NWTN | Jan 31, 2025 | 0.63 | -4.25 |
NXG NextGen Infrastructure Income Fund | NXG | Jan 31, 2025 | 48.27 | +0.23 |
NXP Semiconductors | NXPI | Jan 31, 2025 | 208.55 | -1.34 |
Nxu | NXU | Jan 31, 2025 | 0.30 | +23.91 |
NYLI CBRE Global Infrastructure Megatrends Term Fund | MEGI | Jan 31, 2025 | 12.49 | -0.08 |
NYSE Arca Biotech Index First Trust | FBT | Jan 31, 2025 | 180.74 | -0.60 |
Nyse Composite | NYA | Jan 31, 2025 | 20 013.00 | -0.97 |
Nyxoah SA | NYXH | Jan 31, 2025 | 10.80 | +2.86 |
O-I Glass | OI | Jan 31, 2025 | 11.94 | +0.51 |
Oak Valley Bancorp | OVLY | Jan 31, 2025 | 25.87 | -0.42 |
Oak Woods Acquisition | OAKU | Jan 31, 2025 | 11.45 | 0.00 |
Oaktree Acquisition III Life Sciences | OACC | Jan 31, 2025 | 9.96 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Jan 31, 2025 | 10.18 | -0.10 |
Oaktree Capital A Pref | OAK-A | Jan 31, 2025 | 22.03 | -2.87 |
Oaktree Capital Group B Pref | OAK-B | Jan 31, 2025 | 22.00 | -0.02 |
Oaktree Specialty | OCSL | Jan 31, 2025 | 16.00 | +1.01 |
Oatly ADR | OTLY | Jan 31, 2025 | 0.62 | -6.97 |
Oblong | OBLG | Jan 31, 2025 | 4.22 | +9.33 |
Occidental Petroleum | OXY | Jan 31, 2025 | 46.65 | -4.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.